Discovery of Covalent Inhibitors of Glyceraldehyde-3-phosphate Dehydrogenase, A Target for the Treatment of Malaria

Discovery of Covalent Inhibitors of Glyceraldehyde-3-phosphate Dehydrogenase, A Target for the Treatment of Malaria Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors On-Bead Screening of a Combinatorial Fumaric Acid Derived Peptide Library Yields Antiplasmodial Cysteine Protease Inhibitors with Unusual Peptide Sequences Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35 Covalent inhibitors of GAPDH: From unspecific warheads to selective compounds Design, synthesis and biological evaluation of novel benzothiazole and triazole analogs as falcipain inhibitors Designing novel inhibitors against falcipain-2 of Plasmodium falciparum Design, Synthesis and Evaluation of Trisubstituted Thiazoles Targeting Plasmodium Falciparum Cysteine Proteases